PANCREAZE: payments to doctors
Payments that named PANCREAZE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $268K
- Providers
- 3,354
- Transactions
- 8,578
- Average per transaction
- $31
The per-transaction average — $31 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,354 providers the average total is $80, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Vivus LLC | $204,000 | 76.2% |
| Vivus, Inc. | $63,766 | 23.8% |